Episode 342 -- How to Conduct an Internal Compliance Site Visit and Review
Public-Private Partnerships
title
Investigations and Cognitive Interviews
Episode 337 -- Nicolas Garcia, GC at Orica, on Compliance Trends and Challenges in Latin America
Implications of the SEC Cybersecurity Disclosure Rule
The Privacy Insider Podcast Episode 4: Don't Be Evil: In the Hot Seat of Data Privacy, Part 1
Privacy Issues from Third-Party Website Tags
Episode 331- NAVEX State of Risk and Compliance Programs
What the Board Should Be Asking About the Compliance Program
Managing Social Media Risk
Compliance Lessons from Dating in Your 50s
Managing Compliance Risk for Human Trafficking and Modern Slavery
Common Scenarios Triggering False Claims Act Violations, Part 3: Claims and Investigations
False Claims Act Insights - The Art and Science of Corporate Compliance in Managing FCA Risk
Preparing for a Government Healthcare Audit
Episode 318 -- LRN's Recent Study Underscores Importance of Ethical Culture and Values-Based Leadership
Understanding the HHS OIG’s General Compliance Program Guidance
Climate Risk, the emerging risk
What's Going on with FCPA?
Learning Objectives: - The Science: The importance of reputation and its impact on ethics, compliance and speak up culture. - Examples: We'll share examples of how various E&C programs are tackling rebranding efforts...more
There are multiple formulations of trust in the business context. Trust Across America has an excellent one which they call Trust Alliance Principles (TAP). ...more
Ethics and compliance officers might often feel like your company’s corporate culture gets tied into knots, with so many groups imposing demands on your organization’s behavior. But really, a better turn of phrase here...more
Waiting to see if your organization’s ethical fabric is as bullet proof as you hope isn’t a great strategy - No executive wants to wake up and find themselves on the cover of the Wall Street Journal, exposed in some...more
Recently, the Chinese government reported that GlaxoSmithKline (GSK) would agree to pay almost $500 million in fines to settle allegations of bribery, and that some former GSK employees would receive prison sentences. While...more